Cite

HARVARD Citation

    Middeke, J. et al. (2016). TP53 mutation in patients with high‐risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation. British journal of haematology. pp. 914-922. [Online]. 
  
Back to record